BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu W, Zhang Z, He S, Wong G, Banadyga L, Qiu X. Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model. Antiviral Res 2018;151:39-49. [PMID: 29369776 DOI: 10.1016/j.antiviral.2018.01.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Escaffre O, Juelich TL, Neef N, Massey S, Smith J, Brasel T, Smith JK, Kalveram B, Zhang L, Perez D, Ikegami T, Freiberg AN, Comer JE. STAT-1 Knockout Mice as a Model for Wild-Type Sudan Virus (SUDV). Viruses 2021;13:1388. [PMID: 34372594 DOI: 10.3390/v13071388] [Reference Citation Analysis]
2 Liu XH, Zhang X, Lu ZH, Zhu YS, Wang T. Potential molecular targets of nonstructural proteins for the development of antiviral drugs against SARS-CoV-2 infection. Biomed Pharmacother 2021;133:111035. [PMID: 33254013 DOI: 10.1016/j.biopha.2020.111035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yaylaci S, Dheir H, Şenocak D, Genc AB, Kocayigit H, Çekiç D, Varım C, Aydın A, Koroglu M, Karabay O. The effects of favipiravir on hematological parameters of covıd-19 patients. Rev Assoc Med Bras (1992) 2020;66Suppl 2:65-70. [PMID: 32965359 DOI: 10.1590/1806-9282.66.S2.65] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
4 Hushmandi K, Bokaie S, Hashemi M, Moghadam ER, Raei M, Hashemi F, Bagheri M, Habtemariam S, Nabavi SM. A review of medications used to control and improve the signs and symptoms of COVID-19 patients. Eur J Pharmacol 2020;887:173568. [PMID: 32956644 DOI: 10.1016/j.ejphar.2020.173568] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Ristanović ES, Kokoškov NS, Crozier I, Kuhn JH, Gligić AS. A Forgotten Episode of Marburg Virus Disease: Belgrade, Yugoslavia, 1967. Microbiol Mol Biol Rev 2020;84:e00095-19. [PMID: 32404328 DOI: 10.1128/MMBR.00095-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Shiraki K, Daikoku T. Favipiravir, an anti-influenza drug against life-threatening RNA virus infections. Pharmacol Ther 2020;209:107512. [PMID: 32097670 DOI: 10.1016/j.pharmthera.2020.107512] [Cited by in Crossref: 160] [Cited by in F6Publishing: 142] [Article Influence: 80.0] [Reference Citation Analysis]
7 Rojas M, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Ramírez-Santana C, Ansari AA, Gershwin ME, Anaya JM. Ebola virus disease: An emerging and re-emerging viral threat. J Autoimmun 2020;106:102375. [PMID: 31806422 DOI: 10.1016/j.jaut.2019.102375] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 11.3] [Reference Citation Analysis]
8 Wong G, Zhang Z, He S, de La Vega MA, Tierney K, Soule G, Tran K, Fernando L, Qiu X. Marburg and Ravn Virus Infections Do Not Cause Observable Disease in Ferrets. J Infect Dis 2018;218:S471-4. [PMID: 29889278 DOI: 10.1093/infdis/jiy245] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
9 Rahim MN, Zhang Z, He S, Zhu W, Banadyga L, Safronetz D, Qiu X. Postexposure Protective Efficacy of T-705 (Favipiravir) Against Sudan Virus Infection in Guinea Pigs. J Infect Dis 2018;218:S649-57. [PMID: 29982696 DOI: 10.1093/infdis/jiy303] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
10 Comer JE, Escaffre O, Neef N, Brasel T, Juelich TL, Smith JK, Smith J, Kalveram B, Perez DD, Massey S, Zhang L, Freiberg AN. Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir. Viruses 2019;11:E137. [PMID: 30717492 DOI: 10.3390/v11020137] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
11 Huchting J, Vanderlinden E, Winkler M, Nasser H, Naesens L, Meier C. Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors. J Med Chem 2018;61:6193-210. [PMID: 29906392 DOI: 10.1021/acs.jmedchem.8b00617] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]